Evidence map›Paper›PMID 33746757›Full record

ArticleFrontiers in pharmacology2021

Kaempferol Alleviates Oxidative Stress and Apoptosis Through Mitochondria-dependent Pathway During Lung Ischemia-Reperfusion Injury.

Chunli Yang, Wenkai Yang, Zhaohui He, Jinghua Guo, Xiaogang Yang, Rongsheng Wang, Hongbo Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Advances in sirtuin research in lung diseases (Review).International journal of molecular medicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chunli YangDepartment of Intensive Care, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Wenkai YangDepartment of Cardiovascular Surgery, Central People's Hospital of Zhanjiang, Zhanjiang, China.
Zhaohui HeDepartment of Intensive Care, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Jinghua GuoDepartment of Intensive Care, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Xiaogang YangDepartment of Intensive Care, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Rongsheng WangDepartment of Intensive Care, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Hongbo LiDepartment of Orthopedics, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Jiangxi Provincial People's Hospital · CNCentral People's Hospital of Zhanjiang · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In previous study, we reported that kaempferol ameliorates significantly lung ischemia-reperfusion injury (LIRI), and may be achieved by targeting the SIRT 1 pathway. This study further explored the anti-LIRI mechanism of kaempferol.

Indexed as

apoptosiskaempferollung ischemia-reperfusion injurymitochondriaoxidative stressPGC-1αSIRT1

Identifiers

PMID33746757
PMCPMC7969663
OpenAlexW3135565936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.